ABREVA RAPID PAIN RELIEF- glycerin, lidocaine gel

ABREVA by

Drug Labeling and Warnings

ABREVA by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]


Trademark Results [ABREVA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ABREVA
ABREVA
86790357 4932565 Live/Registered
GlaxoSmithKline Consumer Healthcare (UK) IP Limited
2015-10-16
ABREVA
ABREVA
86790349 not registered Dead/Abandoned
GlaxoSmithKline Consumer Healthcare (UK) IP Limited
2015-10-16
ABREVA
ABREVA
85708911 4317131 Live/Registered
SmithKline Beecham (Cork) Limited
2012-08-21
ABREVA
ABREVA
85582078 not registered Dead/Abandoned
SmithKline Beecham (Cork) Limited
2012-03-28
ABREVA
ABREVA
78023883 2550142 Dead/Cancelled
SMITHKLINE BEECHAM (CORK) LIMITED
2000-08-31
ABREVA
ABREVA
78023878 2492774 Dead/Cancelled
SMITHKLINE BEECHAM (CORK) LIMITED
2000-08-31
ABREVA
ABREVA
78023873 2502156 Dead/Cancelled
SMITHKLINE BEECHAM (CORK) LIMITED
2000-08-31
ABREVA
ABREVA
77426076 not registered Dead/Abandoned
SMITHKLINE BEECHAM (CORK) LIMITED
2008-03-19
ABREVA
ABREVA
75571530 2464248 Live/Registered
GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED
1998-10-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.